These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 21262859

  • 21. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L, Eap CB.
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [Abstract] [Full Text] [Related]

  • 22. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
    Cookson J, Hodgson R, Wildgust HJ.
    J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
    [Abstract] [Full Text] [Related]

  • 23. The effects of atypical antipsychotics on serum prolactin levels.
    Hamner M.
    Ann Clin Psychiatry; 2002 Sep; 14(3):163-73. PubMed ID: 12585566
    [Abstract] [Full Text] [Related]

  • 24. Re: Prolactin levels and adverse events in patients treated with risperidone.
    Denisov MF.
    J Clin Psychopharmacol; 2002 Oct; 22(5):538-40; author reply 540-1. PubMed ID: 12352286
    [No Abstract] [Full Text] [Related]

  • 25. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA, Ellingrod VL, Acion L, Miller DD, Moline J, Tansey MJ, Schlechte JA.
    Pharmacogenet Genomics; 2009 May; 19(5):373-82. PubMed ID: 19339912
    [Abstract] [Full Text] [Related]

  • 26. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
    Stubbs B.
    J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
    [Abstract] [Full Text] [Related]

  • 27. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT, Miller AH.
    Psychopharmacol Bull; 2002 Nov; 36(1):143-64. PubMed ID: 12397853
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ, Gilmore JA, Liu H, Halbreich UM.
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [Abstract] [Full Text] [Related]

  • 29. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 30. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
    Cavallaro R, Cocchi F, Angelone SM, Lattuada E, Smeraldi E.
    J Clin Psychiatry; 2004 Feb; 65(2):187-90. PubMed ID: 15003071
    [Abstract] [Full Text] [Related]

  • 31. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
    Kinon BJ, Gilmore JA, Liu H, Halbreich UM.
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():69-82. PubMed ID: 12650682
    [Abstract] [Full Text] [Related]

  • 32. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R, Mongini F.
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [Abstract] [Full Text] [Related]

  • 33. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
    Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Ikeda M, Ozaki N.
    Pharmacogenomics J; 2003 Dec; 3(6):356-61. PubMed ID: 14610521
    [Abstract] [Full Text] [Related]

  • 34. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
    Konarzewska B, Szulc A, Popławska R, Galińska B, Juchnowicz D.
    Psychiatr Pol; 2008 Dec; 42(1):87-95. PubMed ID: 18567406
    [Abstract] [Full Text] [Related]

  • 35. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V.
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [Abstract] [Full Text] [Related]

  • 36. Risperidone-induced hyperprolactinemia in adolescents: A case series.
    Madhusoodanan S, Moise D.
    J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
    [Abstract] [Full Text] [Related]

  • 37. Hyperprolactinaemia in early psychosis-not only due to antipsychotics.
    Aston J, Rechsteiner E, Bull N, Borgwardt S, Gschwandtner U, Riecher-Rössler A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1342-4. PubMed ID: 20188136
    [Abstract] [Full Text] [Related]

  • 38. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.
    Melkersson KI.
    Hum Psychopharmacol; 2006 Dec 01; 21(8):529-32. PubMed ID: 17094165
    [Abstract] [Full Text] [Related]

  • 39. Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case series.
    Kawabe K, Horiuchi F, Ueno S.
    Clin Neuropharmacol; 2013 Dec 01; 36(6):239-41. PubMed ID: 24201238
    [Abstract] [Full Text] [Related]

  • 40. Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
    Tschoner A, Engl J, Rettenbacher MA, Kaser S, Ott HW, Fleischhacker WW, Patsch JR, Ebenbichler CF.
    J Clin Psychiatry; 2009 Feb 01; 70(2):293-4. PubMed ID: 19265646
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.